Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated DFT and Cyclic Voltammetry Approach for Screening Redox-Active Knoevenagel Adducts with Potential Antioxidant Applicability.

ACS omega·2026
Same author

Low Conspicuity of Ventral Spinal CSF Leaks in the Thoracolumbar Junction in Dynamic CT Myelography: Influence of Trendelenburg Position and Pressure.

AJNR. American journal of neuroradiology·2026
Same author

Accessory Dural Sleeve: Imaging Appearance on Lateral Decubitus CT Myelography and Relationship to CSF-Venous Fistulas.

AJNR. American journal of neuroradiology·2026
Same author

Identification of Potential Pteridin Reductase-1 Inhibitors for the Treatment of Leishmaniasis: A Bioinformatics Approach.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Integrating Chemo- and Bioinformatics with <i>In Vitro</i> Biological Assays to Discover Potential ACE2 and Mpro Inhibitors against SARS-CoV-2.

Journal of chemical information and modeling·2025
Same author

Identification of Inhibitors with Potential Anti-Prostate Cancer Activity: A Chemoinformatics Approach.

Pharmaceuticals (Basel, Switzerland)·2025

Related Experiment Video

Updated: Sep 7, 2025

Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model
07:03

Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model

Published on: February 3, 2021

2.8K

Hierarchical Virtual Screening Based on Rocaglamide Derivatives to Discover New Potential Anti-Skin Cancer Agents.

Igor V F Dos Santos1,2, Rosivaldo S Borges1,3, Guilherme M Silva4,5

  • 1Modeling and Computational Chemistry Laboratory, Federal University of Amapá, Macapá, Brazil.

Frontiers in Molecular Biosciences
|June 20, 2022
PubMed
Summary

This study explored natural compounds for skin cancer (SC) treatment. Virtual screening identified 10 promising molecules, derived from Rocaglamide A, as potential new anti-SC agents for further research.

Keywords:
anticancer activityhierarchical virtual screeningpharmacophorerocaglamideskin cancer

More Related Videos

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

2.9K
A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
08:43

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

10.5K

Related Experiment Videos

Last Updated: Sep 7, 2025

Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model
07:03

Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model

Published on: February 3, 2021

2.8K
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

2.9K
A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
08:43

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

10.5K

Area of Science:

  • Medicinal Chemistry
  • Computational Drug Discovery
  • Oncology

Background:

  • Skin cancer (SC) is a prevalent global cancer.
  • Natural products, like Rocaglamide A (Roc-A), show potential as SC therapeutics.
  • Molecular modeling offers a promising strategy for discovering novel SC treatments.

Purpose of the Study:

  • To identify novel chemical entities with potential anti-skin cancer activity.
  • To virtually screen Roc-A derivatives against skin cancer targets.
  • To develop and validate pharmacophore models for drug discovery.

Main Methods:

  • Hierarchical virtual screening of Roc-A derivatives.
  • Molecular docking studies against Checkpoint kinase 1 (Chk1).
  • Pharmacophore model development and validation.
  • Prospective virtual screening against the Molport database.
  • Toxicity, pharmacokinetic, and consensus molecular docking analyses.

Main Results:

  • 15 Roc-A molecules were used for initial docking and model building.
  • Pharmacophore models were validated using Pearson's correlation and HCA.
  • Prospective screening yielded 10 promising compounds similar to Roc-A.
  • Selected compounds demonstrated favorable predicted properties and structural features.

Conclusions:

  • The 10 identified compounds represent potential novel anti-skin cancer agents.
  • Further biological testing is warranted to confirm their therapeutic efficacy.
  • This study highlights the utility of virtual screening in natural product-based drug discovery for SC.